A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget's disease

Authors
Publication date
1 January 2006
Publisher
Springer London Ltd

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    DIAL UCLouvain

    redirect
    oaioai:dial.uclouvain.be:boreal:5...
    Last time updated on 14/05/2016

    DIAL UCLouvain

    redirect
    oaioai:dial.uclouvain.be:boreal:5...
    Last time updated on 14/05/2016

    DIAL UCLouvain

    redirect
    oaioai:dial.uclouvain.be:boreal:5...
    Last time updated on 14/05/2016